Related Experiment Videos
[The vascular wall and fibrinolysis--pathologic aspects]
Folia Haematologica (Leipzig, Germany : 1928)
|January 1, 1986
Summary
Tissue plasminogen activator (t-PA) levels decrease in conditions like varicosis, diabetic nephropathy, and viral pneumonia. An increase in t-PA is only seen with mechanical tissue damage, suggesting therapeutic implications.
Area of Science:
- Biochemistry and Molecular Biology
- Physiology
- Pathology
Context:
- Investigates the levels of tissue plasminogen activator (t-PA), a key enzyme in fibrinolysis.
- Examines t-PA activity in various pathological conditions and in response to specific therapies.
- Considers the role of extrinsic plasminogen activation inhibitors.
Purpose:
- To determine the levels of tissue plasminogen activator (t-PA) in different disease states.
- To identify conditions associated with diminished or increased t-PA activity.
- To explore the potential implications of these findings for disease pathogenesis and therapeutic strategies.
Summary:
- Tissue plasminogen activator (t-PA) is diminished in varicosis (with and without postthrombotic syndrome), diabetic nephropathy, viral pneumonia, and following cyclophosphamide therapy.
- An elevation in t-PA levels is observed exclusively in cases of mechanical tissue damage.
- The study discusses the significance of these observations for understanding disease mechanisms and treatment approaches, considering potential influences of plasminogen activation inhibitors.
Impact:
- Provides insights into the role of fibrinolysis in various diseases.
- Suggests potential diagnostic or prognostic value of t-PA levels.
- Highlights avenues for therapeutic intervention targeting the fibrinolytic system.